...
首页> 外文期刊>Heart and vessels: An international journal >Follow-up tests and outcomes for patients undergoing percutaneous coronary intervention: analysis of a Japanese administrative database
【24h】

Follow-up tests and outcomes for patients undergoing percutaneous coronary intervention: analysis of a Japanese administrative database

机译:正在经皮冠状动脉干预的患者进行后续测试和结果:分析日本行政数据库

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Follow-up tests after percutaneous coronary intervention (PCI) are considered inappropriate for asymptomatic patients. Despite this perception, many cardiologists conduct follow-up tests as routine practice. The objective of this study was to investigate the survival benefits of follow-up testing after PCI in a real-world setting in Japan. A nationwide Japanese administrative database was used to identify unselected patients who underwent PCI with stent implantation between January 2010 and December 2013. We used time-dependent Cox proportional hazards models to evaluate the association between follow-up testing and outcomes. The primary outcome was the composite of all-cause death and acute myocardial infarction (AMI). Among a total of 21,409 patients, 15,095 (70.5%) completed follow-up testing, of whom 9814 (45.0%) underwent coronary angiography. During a median of 2.7years of observation, the primary outcome occurred less frequently for patients who underwent follow-up testing (1.21 vs. 4.51% per year; adjusted hazard ratio, 0.59; 95% CI 0.52-0.67; p0.001). Individual rates of all-cause death and AMI were also lower for the patients who underwent follow-up testing. Follow-up testing was associated with a lower risk of all-cause death and/or AMI. However, because of the unexpectedly large effect and many limitations of the administrative data, our findings should be further investigated to assess the net benefit of follow-up tests. In addition, we do not intend to encourage routine follow-up tests for patients without clear clinical indications. Follow-up tests should be conducted in accordance with clinical indications.
机译:经皮冠状动脉干预(PCI)后的后续试验被认为不适合无症状患者。尽管有这种看法,许多心脏病学家也会作为常规实践进行后续测试。本研究的目的是调查PCI在日本真实世界中的PCI后续测试的生存效益。 NationWide日本行政数据库用于识别未选择的未选择性患者,在2010年1月至2013年1月之间进行支架植入支架植入。我们使用时间依赖的Cox比例危险模型来评估后续测试和结果之间的关联。主要结果是全因死亡和急性心肌梗死(AMI)的复合物。共有21,409名患者中,15,095名(70.5%)完成后续检测,其中9814(45.0%)接受冠状动脉造影。在观察2.7年的中位数期间,对于接受后续检测的患者(每年1.21与4.51%的危险比,0.59; 95%CI 0.52-0.67; P <0.001),初级结果较少发生频率较少对于接受后续测试的患者,所有因果死亡和AMI的个人率也降低了。随访测试与全导致死亡和/或AMI的风险较低。但是,由于出乎意料的效果和行政数据的许多限制,我们的调查结果将进一步调查,以评估后续测试的净利润。此外,我们不打算鼓励没有明确的临床适应症的患者进行常规后续测试。应按照临床适应症进行后续测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号